Shares of Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) have received an average recommendation of “Buy” from the twenty-two research firms that are currently covering the company. Eleven analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $16.00.

Several equities research analysts have weighed in on MDRX shares. Leerink Swann raised shares of Allscripts Healthcare Solutions from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $16.00 to $17.00 in a research note on Tuesday, August 23rd. FBR & Co reaffirmed a “hold” rating on shares of Allscripts Healthcare Solutions in a research note on Wednesday, June 29th. Cowen and Company downgraded shares of Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $17.00 to $14.00 in a research note on Thursday, September 8th. Piper Jaffray Cos. reaffirmed a “neutral” rating and issued a $15.00 price target (up from $12.00) on shares of Allscripts Healthcare Solutions in a research note on Monday, August 8th. Finally, Zacks Investment Research raised shares of Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research note on Thursday, July 7th.

In other news, CEO Paul Black sold 15,000 shares of the business’s stock in a transaction that occurred on Thursday, September 15th. The shares were sold at an average price of $13.00, for a total value of $195,000.00. Following the sale, the chief executive officer now owns 1,177,009 shares of the company’s stock, valued at $15,301,117. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Dennis Olis sold 7,000 shares of the business’s stock in a transaction that occurred on Monday, July 11th. The shares were sold at an average price of $14.00, for a total transaction of $98,000.00. Following the completion of the sale, the senior vice president now directly owns 210,887 shares in the company, valued at approximately $2,952,418. The disclosure for this sale can be found here. 0.75% of the stock is currently owned by insiders.

Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. raised its stake in Allscripts Healthcare Solutions by 4.1% in the second quarter. Vanguard Group Inc. now owns 14,103,114 shares of the company’s stock valued at $179,110,000 after buying an additional 561,744 shares during the period. BlackRock Institutional Trust Company N.A. raised its stake in Allscripts Healthcare Solutions by 9.6% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 5,928,891 shares of the company’s stock valued at $75,297,000 after buying an additional 518,897 shares during the period. State Street Corp raised its stake in Allscripts Healthcare Solutions by 1.2% in the first quarter. State Street Corp now owns 4,936,217 shares of the company’s stock valued at $65,205,000 after buying an additional 56,931 shares during the period. Fiduciary Management Inc. WI raised its stake in Allscripts Healthcare Solutions by 26.0% in the second quarter. Fiduciary Management Inc. WI now owns 4,101,075 shares of the company’s stock valued at $52,084,000 after buying an additional 846,600 shares during the period. Finally, Schwab Charles Investment Management Inc. raised its stake in Allscripts Healthcare Solutions by 20.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 2,421,644 shares of the company’s stock valued at $30,755,000 after buying an additional 409,140 shares during the period.

Allscripts Healthcare Solutions (NASDAQ:MDRX) opened at 13.02 on Thursday. Allscripts Healthcare Solutions has a 12-month low of $11.47 and a 12-month high of $15.78. The firm has a 50-day moving average of $13.17 and a 200 day moving average of $13.25. The company has a market capitalization of $2.43 billion, a PE ratio of 813.75 and a beta of 1.09.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last posted its quarterly earnings results on Thursday, August 4th. The company reported $0.14 earnings per share for the quarter, meeting the consensus estimate of $0.14. Allscripts Healthcare Solutions had a net margin of 0.20% and a return on equity of 5.34%. The firm earned $386.50 million during the quarter, compared to the consensus estimate of $403.13 million. During the same period in the previous year, the firm posted $0.12 earnings per share. The business’s revenue was up 2.9% compared to the same quarter last year. Analysts forecast that Allscripts Healthcare Solutions will post $0.59 EPS for the current fiscal year.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Company operates through two segments: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services.

5 Day Chart for NASDAQ:MDRX

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.